EpiAxis Therapeutics
PrivateLast Round
Early Funding
Jun 9, 2022
Total Funding Raised
$890,000
Company Overview
EpiAxis Therapeutics is a biotechnology company that develops epigenetic-based treatments intended to prevent metastatic cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EpiAxis Therapeutics Comparables
Compare EpiAxis Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Benz Sciences Inc. | 77% | |
| Merck & Co., Inc. | 77% | |
| Jubilant Pharmova Limited | 76% |
EpiAxis Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jun 9, 2022 | ||||
| VC Round | Dec 18, 2020 | ||||
| Seed | Feb 11, 2016 |
EpiAxis Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sydney Angels | VC Round |
| ANU Connect Ventures | Seed |
| ACT Government | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 11, 2016
$890K raised with ANU Connect Ventures and ACT Government.
EpiAxis Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about EpiAxis Therapeutics's valuation, stock price, and market status.
Is EpiAxis Therapeutics a public or private company?
EpiAxis Therapeutics is a private company.
What is the current stock price of EpiAxis Therapeutics?
EpiAxis Therapeutics is a private company, so its shares have no public market price. Caplight tracks EpiAxis Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is EpiAxis Therapeutics worth (valuation)?
Valuation information for EpiAxis Therapeutics is not publicly available.
Can I buy EpiAxis Therapeutics stock?
EpiAxis Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was EpiAxis Therapeutics's last funding round?
EpiAxis Therapeutics's most recent funding round was Early Funding on June 9, 2022.
Who are the main investors in EpiAxis Therapeutics?
Key investors in EpiAxis Therapeutics include Sydney Angels, ANU Connect Ventures, ACT Government.
Will EpiAxis Therapeutics IPO soon?
No public IPO plans have been announced for EpiAxis Therapeutics.
How can I track EpiAxis Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in EpiAxis Therapeutics's shares on secondary markets.